跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,613 条关于
“Mirum Pharma”
全部
9,613
临床试验
4,082
药物
1,113
机构
1,221
资讯
3,197
去年
Mirum Pharmaceuticals Advances in Liver Disease Treatments
去年
Volixibat Receives FDA Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
9个月前
Mirum Pharmaceuticals Acquires Bluejay Therapeutics for $620M to Advance Breakthrough HDV Treatment
2个月前
Financial Headwinds Mount for Milestone and Mirum Pharmaceuticals as Both Burn Through Cash
9个月前
Mirum Pharmaceuticals Initiates Phase II Trial of MRM-3379 for Fragile X Syndrome
去年
Mirum Pharmaceuticals Completes Enrollment in Phase 2b VISTAS Study for Primary Sclerosing Cholangitis Treatment
去年
Mirum Pharmaceuticals Raises 2025 Revenue Guidance to $490-510 Million Following Strong Q2 Performance
去年
Mirum Pharmaceuticals to Launch Phase 2 Trial of MRM-3379 for Fragile X Syndrome
2年前
FDA Expands Livmarli Approval for PFIC Patients Aged 12 Months and Older
去年
Livmarli Shows Long-Term Efficacy in Relieving Itch for Adolescents with Alagille Syndrome
第 1 页,共 320 页
上一页
下一页